<SEC-DOCUMENT>0000849146-23-000196.txt : 20231030
<SEC-HEADER>0000849146-23-000196.hdr.sgml : 20231030
<ACCEPTANCE-DATETIME>20231030090011
ACCESSION NUMBER:		0000849146-23-000196
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20231030
DATE AS OF CHANGE:		20231030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				900224471
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		231357680

	BUSINESS ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14a-fifeletter.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ieb19cabcd80445599438de87ae0b58e4_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">____________________ </font></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Schedule 14A Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amendment No. )</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">____________________ </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed by the Registrant </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed by a party other than the Registrant </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Check the appropriate box&#58;</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Preliminary Proxy Statement</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Definitive Proxy Statement</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Definitive Additional Materials</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Soliciting Material under &#167;240.14a-12</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">LIFEVANTAGE CORPORATION</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Name of Registrant as Specified In Its Charter)</font></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Payment of Filing Fee (Check all boxes that apply)&#58;</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No fee required</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fee paid previously with preliminary materials</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="ieb19cabcd80445599438de87ae0b58e4_69"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On October 30, 2023, LifeVantage Corporation issued the following press release&#58;</font></div><div><font><br></font></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:371px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LifeVantage President and CEO Steve Fife Sends Letter to Stockholders</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Reminds Stockholders to Vote the WHITE Proxy Card to Ensure Continued Progress</font></div><div><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Salt Lake City, UT, October 30, 2023</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq&#58; LFVN) (&#8220;LifeVantage&#8221; or the &#8220;Company&#8221;), a leading health and wellness company with products designed to activate optimal health processes, today sent the following letter to stockholders from President and Chief Executive Officer, Steven R. Fife, highlighting the importance of retaining critical directors Garry Mauro, Michael A. Beindorff and Darwin K. Lewis to ensure the Company&#8217;s continued progress&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dear Fellow LifeVantage Stockholders&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">When I joined LifeVantage as Chief Financial Officer in 2017, the direct selling industry was undergoing intense change. Broad trends, like the shift to e-commerce, the rise of social media, the proliferation of new digital tools and the growth of the &#8220;gig economy,&#8221; were shaping our business, and those trends were accelerated by the COVID-19 pandemic. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Direct selling companies have faced a challenging market, and many of our competitors have struggled to adapt to this new environment. Since I joined LifeVantage, </font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">our five public direct selling peers have lost nearly 40% of their aggregate enterprise value</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> All but one of our peers are less valuable today than they were six years ago.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LifeVantage has avoided the same fate because our Board of Directors, led by Garry Mauro as Chair, recognized these rapidly changing industry dynamics and took decisive action to reposition the Company to address our challenges and capitalize on our many opportunities. The Board led the effort to rebuild our leadership team and refine our strategy.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">In an industry where so many have failed, LifeVantage has thrived</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Since we announced our new LV360 strategy in January 2023, LifeVantage has generated a total return of 133%,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> which is </font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">among the best returns for any U.S. public company</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in any industry. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">During this transformation, we have benefitted greatly from the fresh perspectives of our newer directors, including Cynthia Latham, a direct selling industry veteran whose expertise in health and wellness is tailor-made to help oversee the execution our strategy. Just as important, though, has been the deep understanding of our business, strong relationships with our consultants and critical institutional knowledge that our more experienced directors provide. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As I write to you, our 2023 Annual Meeting of Stockholders is just days away. At this meeting, two stockholders are seeking to remove three vitally important, experienced </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Source&#58; FactSet. Data from March 12, 2017 to October 25, 2023. Our &#8220;direct selling peers&#8221; include Herbalife, Mannatech, Nature&#8217;s Sunshine Products, Nu Skin Enterprises and USANA Health Sciences.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Source&#58; FactSet. Data as of October 25, 2023.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">directors. In my view, the removal of any of these individuals would be a huge loss for the Company and its stockholders.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Garry Mauro, our Chair, is an important voice in our boardroom</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and is adept at focusing the Board&#8217;s discussions on critical issues as well as challenging the leadership team to improve performance. Garry is known and respected by our consultants, who look to him as a source of stability and continuity during a time of significant change. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Michael Beindorff and Darwin Lewis also have critical roles on the Board, including leading our Compensation Committee and Audit Committee, respectively. Michael is one of the Board&#8217;s foremost marketing experts, with experience in senior marketing roles at Coca-Cola and VISA. Darwin provides valuable knowledge of international markets gained over three decades at one of the world&#8217;s largest global consumer packaged goods companies, SC Johnson &#38; Son. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">During this period of transformation, </font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">it is critical that we retain the expertise that Garry, Michael and Darwin uniquely provide</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. It would be unwise, in my view, to disrupt the balance we have achieved in the boardroom of fresh insights and deep experience and knowledge of our industry, operations and history. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I appreciate your investment and your support and ask that you please vote for all of the Company&#8217;s director nominees using our white proxy card. Help us continue our progress and strong momentum by ensuring that our Board retains valuable institutional knowledge and experience as we chart our course forward.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sincerely,</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Steven R. Fife</font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LifeVantage strongly recommends that stockholders vote &#8220;FOR&#8221; ALL of the Company&#8217;s highly qualified and experienced director candidates using the WHITE universal proxy card.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stockholders who have any questions or need assistance voting their shares are encouraged to contact the Company&#8217;s proxy solicitor, Morrow Sodali LLC, at (800) 662-5200 or LFVN.info&#64;investor.morrowsodali.com.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">About LifeVantage Corporation</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LifeVantage Corporation (Nasdaq&#58; LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &#38; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim&#174; family of products, LifeVantage&#174; Omega+, ProBio, IC Bright&#174;, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience&#174; line of skin, hair, bath &#38; body, and targeted relief products. The Company also markets and sells Petandim&#174;, its companion pet supplement formulated to combat oxidative stress in dogs, Axio&#174; its nootropic energy drink mixes, and PhysIQ, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Cautionary Note Regarding Forward Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;hopes,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;look forward to,&#8221; &#8220;goal,&#8221; &#8220;may be,&#8221; and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and&#47;or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, the impact of COVID-19 on our business, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company&#8217;s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company&#8217;s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company&#8217;s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments as a result of future COVID-19 developments, as well as those discussed in greater detail in the Company&#8217;s Annual Report on Form 10-K and the Company&#8217;s Quarterly Report on Form 10-Q under the caption &#8220;Risk Factors,&#8221; and in other documents filed by the Company from time to time with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Important Additional Information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company, its directors and certain of its executive officers are participants in the solicitation of proxies from the Company&#8217;s stockholders in connection with the 2024 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;). The Company filed its definitive proxy statement and a </font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WHITE</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> universal proxy card with the SEC on September 22, 2023 in connection with any such solicitation of proxies from the Company&#8217;s stockholders. </font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH PROXY STATEMENT, ACCOMPANYING WHITE UNIVERSAL PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION.</font><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The Company&#8217;s definitive proxy statement for the Annual Meeting contains information regarding the direct and indirect interests, by security holdings or otherwise, of the Company&#8217;s directors and executive officers in the Company&#8217;s securities. Information regarding subsequent changes to their holdings of the Company&#8217;s securities can be found in the SEC filings on Forms 3, 4 and 5, which are available on the Company&#8217;s website at investor.lifevantage.com&#47;financial-information&#47;sec-filings or through the SEC&#8217;s website at www.sec.gov. Information can also be found in the Company&#8217;s other SEC filings, including its Annual Report on Form 10-K for the year ended June 30, 2023, filed on August 28, 2023. Stockholders can obtain the definitive proxy statement, any amendments or supplements to the proxy statement and other documents filed by the Company with the SEC at no charge at the SEC&#8217;s website at www.sec.gov. Copies are also available at no charge on the Company&#8217;s website at investor.lifevantage.com&#47;financial-information&#47;sec-filings.</font></div><div><font><br></font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Investor Relations Contact&#58;</font></div><div><font><br></font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reed Anderson, ICR</font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(646) 277-1260</font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reed.anderson&#64;icrinc.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Media Relations Contact&#58;</font></div><div><font><br></font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dan McDermott, ICR</font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dan.McDermott&#64;icrinc.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "1 KT# 2(  A$! Q$!_\0
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M4@N\#/'D&7?NX^[C)]*[;X*?\%*/&7PVU5_#/Q?TJYUF.WF,,M\L0@U"U(W
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M836D>+2=L=)(AT[<ICZ&OHHYAA\<E3S".O\ ,M_G_7R/&E@ZV%?/@Y:?RO\
M3^OF?4>DZQ8Z]I\%_IMY!?V4ZAXKBWD#HX/<$<&KE?CW:ZO\>/\ @GWXJ%K.
MDK>'YY,^3)NN-,NQG)*G^!\$],-Z@XK[I_9W_;W^'_QOM[73]2N8_"7BIP%?
M3KZ4"*5\$GR93@,.#P<'I7)BLJJT8^UHOGAW7ZG1A\PIU9>SJ+EGV9]-T54U
M/5['1;;[1J%[;V%ON"^;=2K&F3T&6(&:K:7XIT77)VATW5[#4)E7>T=K<I*P
M7(&2%)XR1^=>+RNU['J75[&I1114C"BBB@ HHHH **** "BBB@ HJ*ZNH+*%
MIKB:.")>LDK!5'XFG1R)-&LD;K)&PRK*<@CU!IV=KBYE>W4?1112&%%<#\2O
MC9X7^%L935KSS-0*;X["W&Z5N"5SV4$KC)KPW6/VY'6]8:7X95[3 PUU.0Y/
M?@#%>WA,EQ^-CST:;Y>[LE^)\MF/%&4974=+$UTI+=*\FO6R=OF?6%%?*.B_
MMR!KHC5O#02WV\-:3DON^C#&*^AOAW\1-)^)WAX:QHYE^S"3R769-K+(%5BO
MOC<.148S*,;@(\^(IV7?1K\#3+.),KSB?L\'6YI;V::=O1I'44445XY]*%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH?\ T(5WY?\ [Y1_Q1_-'D9Q_P BW$_X)_\ I+/S?KWG]C'_ )*Y-_V#IO\
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M:C\/_M,>"_MMGLT_Q)9*JZII!;+0L>DB9^]&Q!P>HZ'GKL?M5?\ )N/Q$_[
MT_\ Z#7S$*4Z&)C3J*S37YGNRJ1JT'.#NFF?A#7V?_P2J!_X:#U;_L!3?^C8
MJ^,*GL[ZYT^0R6T\EO(1@M$Y4X],BOU;%4/K-"5&]KH_/L/5]A5C4M>Q_191
M7\[_ /PDVL?]!2\_[_O_ (T?\)-K'_04O/\ O^_^-?(_ZM/_ )^_A_P3Z/\
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M '[G_P!*)*_/ROT#_95_Y(9X?_W[G_THDK[SB_\ W"'^-?E(_(O#;_D<5/\
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MD.!OAZ<@&15!.#P37B'C3Q5>^./%VL>(-0DDEO-2NI+F0R2-(068D+N/) &
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M7^1\WA/]YI^J_,_2+]M[_DU/XB_]>"_^CHZ_#ZOW!_;>_P"34_B+_P!>"_\
MHZ.OP^KP^'/]VG_B_1'JYU_'CZ?JS]#?^"0__(8^)_\ U[Z?_P"A7%?I-7YL
M_P#!(?\ Y#'Q/_Z]]/\ _0KBOTFKYG._]_J?+\D>YE?^Z0^?YL*_ 7X[_P#)
M</B'_P!C%J/_ *4R5^_5?@+\=_\ DN'Q#_[&+4?_ $IDKU>&_P")4]$<&=_!
M#U92^$O_ "5'PC_V%K7_ -'+7[9?M5?\FX_$3_L#3_\ H-?B;\)?^2H^$?\
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MOL<4[X6H_P"Z_P CYG#Z8B"_O+\SZK_X*\?\@?X8?]=]1_\ 0;:OS9K]@O\
M@I1\)I_B+^SZ^L:?9I<ZGX7N1J!;#&06I4K.$ ]/W;G/ 6(FOQ]KS,BJ1G@H
MQ6\6U^-_U._-H..*<GUM_D?L_P#\$[=<L=7_ &3?"4%G<+/-ITMW:72KUBE^
MT22[3[[)8V_X$*^E*_'?]A/]KR/]G?Q+=Z'XC\V7P5K4BO/(FYVL9QP)E7/*
MD<. ,D*I'W<']<_#7BO1O&6E0ZGH6JV>L:?,H>.YLIEE1E.<$%3['\J^-S;"
M5,/B9S:]V3NGZGTN78B%:A&*>L59KT-6OR _X*>?\G0W/_8)M/Y-7Z^2RI#&
MTDCK'&HW,S'  '<FOQ[_ ."E^H6NI?M.W<EI<PW4:Z7:(S0N' ;:W&1WY%=?
M#_\ O;]'^ASYQ_NR]5^I\J+]X?6OV@_:\_Y,>\3_ /8'L?\ T=!7XOK]X?6O
MWB\?_#]/BG^SGJ/A5H!<2:EH"QP1M)L!G$2M"2W8"14/X5[F>35.KAIRV4K_
M )'E95%SIUXK=K_,_!RO4O@W^S/\0?CY::G<^"-'AU:/372.ZWWT$!C+@E>)
M'4D'!Y'I7FE]9S:=>3VMQ&T4\+M&Z,.58'!%?1/[#O[3T/[-OQ*N6UE9I?"6
MN1I;:B(0"T#*V8KC&,MLW."H(R'8\D 5]!BI5H492PZO);'CX>-.551K.T2Q
M_P .Y/CW_P!"?;_^#>S_ /CM'_#N3X]_]"?;_P#@WL__ ([7[%Z#X@TSQ3I-
MMJFCW]OJ>G7*+)#=6LHDC=6 (((]00?QK0KX9\0XQ.SC'[G_ )GU?]C89ZJ3
M^]?Y'XR?\.Y/CW_T)]O_ .#>S_\ CM:WA'_@GG\==)\5Z->W/A&!+>VO89I&
M_M:T.%5P2<"7/05^PM<[>?$7POI_BBR\-W'B#38=?O@QMM-:Y03R[<[MJ9R<
M8/Y&C^W\9.Z48_<_\P_L?#1U<G]Z_P CH5^Z*6N9^(?Q TOX:^&9=9U7SI$\
MQ+>WM;5#)/=W#G$<,2#[SL> /J3@ FO(++]J:X;4[SS='TJ_MK42-=:3HNLQ
MW>LV*1MB5I8  CE!DLD,COZ \X^>IX>I5CS16A[,ZT*;M)GT+15#0==T_P 4
M:+8ZOI5W'?:;?0K<6US"<I+&PRK ^A!J_6#33LS;?5!7Y??\%9O"<]E\2O!G
MB/>7MK_39+/:$.(VADW<MT^82\#_ &37Z@UYG^T)\!= _:*^'=SX7UTR0$/]
MHLKV+[]K< $+(!T888@@]03TZUZ>6XI8/%1JRVZ_,X,=AWB:$J<=^@W]F?QG
MH_CCX$^"+W1;V.\@ATBUM9=IPT<L4:QNK+U!#(>O48/0UZ=7X_>(/AC\=_V!
M?$O]MZ/=2RZ'*ZA[_3PTUA<@8;;/&?N]"/F /!P>:^N/V<?^"D'@_P")D-MH
M_CDP^#_$C;8Q-(Q^Q7+=,AS_ *LDX^5N.>IKMQ>5SUQ&&?/!]MUZHY</CXZ4
M:ZY)+OL?9-%,AFCN(4EB=98I%#(Z$%6!Z$$=13Z^>/9"BBB@ HHHH **** "
MBF22)#&\DCK'&@+,S'  '4D^E?)'[1'_  49\$?".>[T;PNB^,_$L)*,+>3%
MG X(!#RC[Q^]PF>1R173A\-6Q4^2C&[,*U>G0CS5'9'TC\3OB)I'PH\!ZUXJ
MUN>."QTVV>8K)($,S@'9$I/\3MA0/4BOS<_X)4Z+?:I\=/&'B"&#_B66VC/;
MS2EA\DDT\;1KCOD0R?\ ?-<-I?@WX^_M\>)DU#4)KC^P/,XN[K=;Z7: 'I&@
M^\P$AQC<Q!/-?IM^SW^S[X;_ &<_ </AW0(_.N)");_4I5 FO)L8+-Z*.BKT
M ]R2?H*L:>5X6I0<E*I.UTNB1X].4\?B(5E&T(;7ZGI]%%%?+'OA7 _'K_DC
M_BK_ *]#_P"A"N^KF_B-X7F\:>"-7T.WF2WFO8?*620':O(/./I79@YQIXFE
M.;LE)-_>>;F=*=; UZ5-7E*$DEW;3L?F+3XYGA;=&[(W3*G%?2O_  P[KW_0
MPZ=_WS)_\31_PP[KW_0PZ=_WS)_\37[9_;^5_P#/Y?<_\C^5_P#4_/O^@67W
MQ_S/F_\ M"Z_Y^)?^^S1_:%U_P _$O\ WV:^D/\ AAW7O^AAT[_OF3_XFC_A
MAW7O^AAT[_OF3_XFE_;V5?\ /Y?<_P#(K_5'B#_H&E]\?\SYUL[^Y-U%FXE^
M\/XS7ZCZ=_R#[7_KDO\ (5\BP_L0Z]%(KCQ#IN5.?NR?_$U]?6L)M[6&(G)1
M I(]ABOA.*,?A<:J/U::E;FO:_D?K? .49AE;Q/UZDX<W+:[6MN:^S?='YD?
M$3_D?_$G_82N/_1C5T?[/?\ R63PM_U]K7LWB;]C/6]>\2:IJ4>O:?&EY=27
M"HROD!F+8/R^]:?PU_9)UGP-XXTC79];L;B*RG$K1QJ^Y@.PR*^MK9WETL'*
MFJRYG%KKO;T/SK#<*YU#,Z=>6&?*JB=[QVYD[[]CZ@KY@_;E_P"0'X5_Z[7'
M\HZ^GZ\D_:"^#%]\8K'1[>RO[>Q-B\KL;@,=VX)C& ?[I_.OS+)*]+"YA2K5
MI6BKW?R9^[<582OC\FKX;#1YIRY;+O:2?7R/S\K] _V5?^2&>'_]^Y_]*)*\
M4_X8=U[_ *&'3O\ OF3_ .)KZ2^#W@6X^&OP^TWP]=7,5W/:M*3-""%.^5G&
M,^S5]AQ+FF#QN#C3P]12:DGUVL_(_->!<AS/*\SG6QE%PBX-7;6_-%VT;[,[
M-E#*01D'@BOA/]H_X#W7P_\ $$^KZ/:22^&KMMZM&,BV<\F,XZ+_ '3Z<=1S
M]VU#=VD-_:RVUS$D]O*I22*10RLI&""#U%?'93FE7*J_M(*\7NN__!['Z;Q%
MP_0X@POL:CY9QUC+L_\ )]5_D?E/78>%?B]XQ\%P-!H_B"\M("NT0EO,11DG
MY5;(')/2OJGQ]^QQX=U^26Y\/73Z'<,,BW8&2$GCWW*.OKUKR#5_V-?'%E>&
M.R>QU"# (F2<)SW&&P:_5:>>95CJ?+4FEY37^>GXG\]U^%.(<IJ\U"G)VVE3
M=_RM+[T49OVOOB%+9F 75E&VW;YRVHW_ %],_A7':[\<O'GB2WCAOO$]\T:-
MN A<0Y.,<[ ,_C79?\,@?$/_ )\[/_P+3_&NL\-_L1ZU<FUDUK6K2RC;F:&W
M5I77K@ \ ]N]9?6<APOOQ=/Y)-_@FS?ZCQ?F#]E-5FO[S<5^+2,/]B]BWQ<N
MR22?[*FZ_P#72*ON&O._A;\"_#7PI43:;#)<:HT?ER7\[?.P(7< !P%)4'')
M]Z]$K\TSW'4LQQCK4;\MDM?(_=.$\IQ&2Y8L+BK<]V]-;7Z!7XR?\%!_@^WP
MK_:(U:\M[?RM&\2#^UK5E5MHD8XG7<W5O,RYQT$BU^S=?.O[9G[*)_:@\+:+
M!I]_9Z1KVDW)DAO;N-V4PNN)(OEZ9(1NA^X*RRC&1P>)4INT7HSWLRPSQ-"T
M5>2U1^*U%?>'_#I/QM_T/&@?]^9__B:DA_X))^,O.C\WQSH0BW#>4@F)QWP-
MO6ON_P"UL#_S]7X_Y'R7]G8O_GW^1[5_P2\^#[>#OA)?^,KZU\K4/$<^+=V5
ME?[+'PO4X(+;F! K[5K"\"^#[#X?^#M&\-Z7&L5AI=K':Q*HP,*,9QD]3D_C
M6[7YKC,0\57G6?5_AT/N,-16'HQIKH?DI_P4N^!=[X$^,4OC>TLT7P[XGQ)Y
MD(/[N[50)5?T+'YP>AW'T-?' )4@C@U_0UXL\(Z+XZT&ZT7Q!I=KK&E72E);
M6[C#HP((SST/)P1R.U?"WQ0_X)/:/J5S-=> _%<ND^9(I73]7C,T4:;?FQ*O
MS$YY&1W/-?7Y;G5&-*-'$NS6E^C/G,=E=251U:.J?0\6^#O_  4Z\??#GPM!
MH>OZ3:^-$M(TAM;RZN&AN0B[N)' ;S#@J 2 <+R23FNWOO\ @K9K%Y9SV_\
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MK[6[&%EC::ZC,6I6F6R2VX#S!M;(#8. N#BOT1^$WQJ\&_&[P\NL>$-:@U.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OEKXZ?MV:/^S_\ '"'P7XBT&XGT
M62P@N6U2TD#2QN[/G,9ZJ% Z'.<U]2U^1_\ P5(L[B+]HZ&Y>WF2VFTBW6.9
MHR$D*EMP5L8)&1G'3(]:]K*<-2Q>(]E55U9GEYC7J8>C[2F];H_1GX?_ +5'
MPJ^)D*-HGC72VF-NMP]K=S"WEB4XX8/CD$X(!-=Y'XX\.36QN(_$&EO;CDS+
M>QE!^.[%?ST!B.AQ4JWDZPF)9I!&W5 QP?PKZ*?#=-OW*C2]+_Y'C1SN=O>@
MOO/VO^.W[:WPU^">D3[];M_$&O-%OMM*TN43,Y(;:7=<JBY7DDY]J_&CQYXU
MU/XC>,M7\2ZS.;C4M3N&N)G/J3P![ 8 ]A6"23UYKIOA_P##;Q+\4O$5OHGA
M?1[K5]0F=5"6\9*ID_>=NBK[G KV<#E]'+8RDG=O=O\ K0\S%8RKCI)-:=$C
MJOV9?AK=?%GXY>$?#UO$LD<EZD]SYD9>-88SO?<!V(7'XBOWACC6&-8T4(B@
M*JJ,  =!7S+^Q3^Q_'^S7X?N]1UJ>'4/&>JHJW4L',5K&.1%&2,GGDMQGCTK
MZ<KXK.<='&5TJ;O&.GKW/J,LPLL-2;G\4@HHHKY\]@**** "BBB@ HHHH **
M** "BBB@ HHHH **** /*?CG^S+X"_:"TDV_BC24.H1JPM]6M<1W4!*X!#C[
MP'!VMD':.*_.SXL?L9?%[]E?Q$_BOX;ZGJ6L:1"S-%J&B[EO;=6.P++$OWN'
MQE00?F)"BOUIHKUL'F=?"+D7O0[/8\[$8&EB/>VEW6Y^3\/_  52^*2>%_[/
M?1]"EU7R3&-7,#B3><XD\L-LR..,8XZ51^'_ .R3\:OVOO$S^+?'E_>:+IMQ
M(6?4-;5A*RG/RV]N<84;0!]U0"",XK]7/^$:TC.?[*L<_P#7NG^%:-=SS>G1
M3^J45"3Z[_=I_P  Y?[.G4:^LU7)+IL>2? S]EOX?_L_:<D?AO2$DU0IMFUB
M\ DNY>!GY\?*"1G:N ,FO7***\"I5G6DYU'=L]B%.-./+!604445D6%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !6/XH\'Z'XUTN73M?TBSUBQE1HW@O8%E4JWWA
MR.,X'3TK8HIIN+NA-)JS/FWQ1_P3S^!_BC4IKUO"TFF22J%\O3+N2")<#&50
M':#^%>:WG_!*#X:SWWFP^)?$5M!G/V=7A8?3)3-?;E%>C#,L935HU7]]_P S
MBE@<-+5TT?+WAG_@F_\ !+P[<6-Q+H=YJ]Q;.')O[UWCE(.</&,*1[8Q7T%X
M/\ ^&_A[I::=X:T.PT.R4$"&QMUB'))YP.>2>M;]%<]7%5Z_\6;?JS>G0I4?
MX<4OD%%%%<IN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
